US EditionPublished • loading... • Updated
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index
- WuXi Biologics has been included in the 2025 Hang Seng Corporate Sustainability Benchmark Index, marking a significant achievement for the company.
- It is the only company from the pharmaceutical industry selected for this index, highlighting its unique position.
- The Hang Seng Corporate Sustainability Benchmark Index recognizes companies for outstanding ESG performance, impacting sustainability investments.
- Dr. Chris Chen, WuXi Biologics CEO, stated that this inclusion reflects the company's commitment to sustainability efforts.
Insights by Ground AI
71 Articles
71 Articles
The Berkshire Eagle+69 Reposted by 69 other sources
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index
The only company from pharmaceutical industry selected for inclusion in the IndexAlso included in HSI ESG Index and Hang Seng ESG 50 IndexGreen CRDMO solution provider with outstanding sustainability performance
Coverage Details
Total News Sources71
Leaning Left7Leaning Right8Center20Last UpdatedBias Distribution57% Center
Bias Distribution
- 57% of the sources are Center
57% Center
L 20%
C 57%
R 23%
Factuality
To view factuality data please Upgrade to Premium
